Lannett reported $438.36M in Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amerisourcebergen ABC:US USD 57.91B 1.35B
Ani Pharmaceuticals ANIP:US USD 739.11M 12.22M
Aurora Cannabis Inc ACB:CN CAD 1.17B 85.57M
Canopy Growth Corp WEED:CN CAD 3.4B 115.26M
Cardinal Health CAH:US USD 43.39B 491M
Corcept Therapeutics CORT:US USD 533.26M 36.89M
Depomed DEPO:US USD 323.34M 1.37M
Endo International Ordinary Shares ENDP:US USD 6.01B 355.8M
Knight Therapeutics Inc GUD:CN CAD 1.04B 34.21M
Lannett LCI:US USD 438.36M 28.94M
Ligand Pharmaceuticals LGND:US USD 1.05B 25.68M
Mckesson MCK:US USD 62.69B 391M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Novartis NVS:US USD 117.45B 1.01B
Omeros OMER:US USD 457.55M 111.91M
Pacira Pharmaceuticals PCRX:US USD 1.73B 377K
Perrigo Ordinary Shares PRGO:US USD 10.68B 242.1M
Phibro Animal Health PAHC:US USD 948.38M 16.68M
Prestige Brands PBH:US USD 3.68B 3.72M
Supernus Pharmaceuticals SUPN:US USD 1.69B 1.84M
Teva Pharmaceutical TEVA:IT USD 44.25B 1.68B
Zoetis ZTS:US USD 13.67B 96M